Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$34.83
-0.18-0.53%
Last update: Dec 12, 11:48 AM
Comments
Loading...
Travere Therapeutics (TVTX) Stock Price, Quote, News & History
TVTXNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Travere Therapeutics (TVTX) stock?
You can purchase shares of Travere Therapeutics (NASDAQ:TVTX) through any online brokerage.
Who are Travere Therapeutics (TVTX) competitors?
Other companies in Travere Therapeutics’s space includes: IDEAYA Biosciences Inc (NASDAQ:IDYA), Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), Ascentage Pharma Group International (NASDAQ:AAPG), Arcutis Biotherapeutics Inc (NASDAQ:ARQT) and Xenon Pharmaceuticals Inc (NASDAQ:XENE).
What is the forecast, or price target, for Travere Therapeutics (TVTX) stock?
Travere Therapeutics has a consensus price target of $35.00.
What is the current price for Travere Therapeutics (TVTX)?
The stock price for Travere Therapeutics (NASDAQ: TVTX) is $34.825 last updated December 12, 2025 at 11:48 AM EST.
Does Travere Therapeutics (TVTX) pay a dividend?
There are no upcoming dividends for Travere Therapeutics.
When is Travere Therapeutics (NASDAQ:TVTX) reporting earnings?
Travere Therapeutics does not have any upcoming earnings scheduled.
Is Travere Therapeutics (TVTX) going to split?
There is no upcoming split for Travere Therapeutics.
What sector and industry does Travere Therapeutics (TVTX) operate in?
Travere Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
